Making a Difference, Here & Beyond
The community invests in Dell Med. In return, it’s our responsibility — one we take seriously — to be agents for change and to show real impact.
OUR WORK
More Information
PARTICIPATE
COLLABORATE
Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
WHAT IT MEANS
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
SEE HOW
More Information
Let’s Do Big Things Together
True health demands that the whole work in harmony, which is why we’re dedicated to partnership. Indeed, we can’t achieve our goals without it.
LEARN MORE
More Information
PARTICIPATE
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
Make an Appointment Directory Give Faculty Students

Michela “Micky” Marinelli, Ph.D.

Education

Ph.D., Neuroscience, Pharmacology
University of Bordeaux 2, France

About

Michela (Micky) Marinelli, Ph.D., is an associate professor in the Department of Neurology and a courtesy associate professor in the Department of Psychiatry and Behavioral Sciences.

Marinelli is also an associate professor of neuroscience in the College of Natural Sciences at The University of Texas at Austin and holds an appointment in the Division of Pharmacology and Toxicology in the College of Pharmacy.

Prior to joining UT Austin, Marinelli was a faculty member at the French equivalent of the NIH, Inserm (2000-2003) and at the Chicago Medical School/Rosalind Franklin University of Medicine and Science (2003-2013).

Marinelli’s research seeks to understand the neurobiological bases of drug addiction, with an emphasis on the biological and environmental factors that enhance susceptibility to addiction. The team uses a systems approach, examining and integrating different variables and levels of information to understand how systems work and interact. These variables are studied in rodent models, and they range from the cellular level (neuronal activity, using electrophysiological techniques), to the molecular level (protein expression), to the circuit level (optogenetics and functional neuroanatomy), and to the whole animal level (behavioral studies, such as drug self-administration). Current projects in the lab examine (i) age and sex-differences in the ability to withstand adversity to obtain rewards, (ii) the role of an under-explored brain area (the lateral preoptic area) in reward seeking, and (iii) the interplay between stress and dopamine in mediating addiction liability.

Marinelli served on the National Institute on Drug Abuse’s Board of Scientific Counselors and on numerous study sections. She was the director of the graduate program in cellular and molecular pharmacology at Rosalind Franklin University, and she has taught numerous courses to undergraduate and graduate students as well as to students in health professions (medical, nursing, physician’s assistants, and pharmacy). These include communication skills, interprofessional education, experimental design and data analysis, neurological and psychiatric conditions, neuropharmacology, pharmacology and physiology.

Professional Affiliations
  • Board of Scientific Counselors for the National Institute of Drug Abuse
    2015-Present
  • European Behavioural Pharmacology Society
    2017-Present
  • Federation of European Neuroscience Societies
    2017-Present
  • American Society for Pharmacology & Experimental Therapeutics
    2004-Present
  • Society for Neuroscience
    1999-Present